1. PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review
   Simona Frezzini et al, 2024, International Journal of Molecular Sciences CrossRef
2. Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature
   Zhenhua Zhang et al, 2022, Frontiers in Oncology CrossRef
3. Iatrogenic Leptomeningeal Carcinomatosis Following Craniotomy for Resection of Metastatic Serous Ovarian Carcinoma: A Systematic Literature Review and Case Report
   Brittany M. Stopa et al, 2022, Frontiers in Surgery CrossRef
4. Leptomeningeal Metastases: New Opportunities in the Modern Era
   Jessica A. Wilcox et al, 2022, Neurotherapeutics CrossRef
5. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
   Jessica A. Wilcox et al, 2023, CNS Drugs CrossRef
6. Case report of two long term ovarian cancer survivors with brain metastases following multimodal treatment including chemotherapy, radiotherapy and maintenance olaparib: An institutional case series and literature review
   Yukari Tsuchino et al, 2024, Gynecologic Oncology Reports CrossRef
7. Leptomeningeal Carcinomatosis From Primary Mucinous Carcinoma of the Ovary
   Alexander Dye et al, 2024, Cureus CrossRef
8. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma
   Eunji Yim et al, 2022, BMJ Case Reports CrossRef
9. Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer
   Giulia Scotto et al, 2021, Cells CrossRef